Single‑Field, Single‑Switch: A Framework for Proton Bragg Peak FLASH Radiotherapy Using Universal Range Shifters

Authors:
  • QZQi Zhang
    Qi Zhang
  • HQHong Quan
    Hong Quan
  • BPBo Pang
    Bo Pang
  • MLMuyu Liu
    Muyu Liu
  • SCShuoyan Chen
    Shuoyan Chen
  • HWHexiao Wang
    Hexiao Wang
  • CHCong He
    Cong He
  • QXQingguo Xie
    Qingguo Xie
  • XLXu Liu
    Xu Liu
  • QLQianqian Lin
    Qianqian Lin

Abstract
Background and purpose: Single-field optimization (SFO) is intrinsically attractive for proton Bragg Peak (BP) FLASH radiotherapy (FLASH-RT) because it delivers the entire fractional dose with a single beam, thus reducing field overlap and temporal interruptions that can lead to the degradation of ultra-high dose rate (UHDR) conditions. However, SFO is associated with limited degrees of freedom that pose a challenge for efforts to achieve clinically acceptable dose conformality, particularly for BP proton FLASH delivery. This study presents an SFO-based optimization framework that integrates universal range shifter (URS) modulation to enable single-switch BP proton FLASH-RT with preserved UHDR performance and improved dose conformality.Materials and Methods: A sparsity-promoting inverse planning framework was developed to perform SFO under a single-switch delivery paradigm. For each beam, optimization of URS thickness was performed to position the BP at the distal target edge, with the option of introducing a second URS thickness, allowing only a single URS switch event per beam to enhance longitudinal dose conformality. Beam angles, couch angles, URS configurations, spot weights, and fractional doses were jointly optimized while employing non-uniform fractionation to maintain a cumulative tumor biological effective dose (BED) of 100 Gy. The proposed SFO-based URS-modulated BP FLASH plans were generated for 10 brain, 10 lung, and 10 liver cases, and compared with conventional multi-energy Intensity-Modulated Proton Therapy (IMPT) plans and single-energy transmission beam (TB) FLASH plans with uniform fractionation. Plan quality, delivery efficiency, and dose-rate performance were evaluated through the use of dosimetric indices, beam delivery time, and dose-rate metrics based on dose-averaged dose rate (DADR) and average dose rate (ADR).Results: Across all sites, the SFO-based URS-modulated BP FLASH plans achieved sub-second beam delivery times (0.22 ± 0.06 s for brain; p < 0.001, URS-modulated BP vs. IMPT; 0.14 ± 0.04 s for lung; p = 0.002, URS-modulated BP vs. IMPT; and 0.31 ± 0.11 s for liver; p = 0.006, URS-modulated BP vs. IMPT), compared with 4.3–7.6 s per beam in IMPT plans. Target conformality was substantially improved relative to TB FLASH plans, with conformality indices of 0.62 ± 0.06, 0.64 ± 0.01, and 0.65 ± 0.11 for brain, lung, and liver cases, respectively, compared with 0.35–0.40 for TB plans (p < 0.001, URS-modulated BP vs. TB for all sites), while remaining below those of IMPT (0.81–0.84; p < 0.001, URS-modulated BP vs. IMPT for all sites). In normal tissues, near-complete UHDR coverage based on DADR was achieved for URS-modulated BP plans (>97% across all sites), whereas IMPT plans afforded negligible UHDR coverage (<2%; p < 0.001, URS-modulated BP vs. IMPT for all sites). ADR-based V40Gy/s in normal tissues reached 55.6% ± 4.0% for brain, 70.6% ± 10.4% for lung, and 59.1% ± 6.2% for liver cases in URS-modulated BP plans.Conclusion: Through the explicit formulation of proton FLASH planning within an SFO framework and augmenting it with limited URS-modulated BP modulation, clinically feasible single-switch BP FLASH-RT can be achieved with preserved UHDR conditions, markedly reduced delivery time, and substantially improved dose conformality over transmission FLASH.